Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.
Location: France, Ile-de-France, Lisses
Employees: 501-1000
Founded date: 1967
Investors 2
| Date | Name | Website |
| 09.11.2020 | Montagu Pr... | montagu.co... |
| 03.06.2026 | Warburg Pi... | warburgpin... |
Mentions in press and media 2
| Date | Title | Description |
| 12.10.2017 | Term Sheet — Thursday, October 12 | DRY POWDER Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Things are looking sluggish here too. U.S. private equity firms invested $163.4 billion across 959 private equity deals during the t... |
| 29.06.2017 | Term Sheet — Thursday, June 29 | New Money, Old Deals, Lingering Questions LA Tech: Upfront Ventures has closed its fourth core fund with $400 million in commitments. It’s the firm’s largest ever, and according to managing partner Mark Suster, the largest Los Angeles-based... |